Levi & Korsinsky notifies investors that it has commenced an investigation into Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) concerning potential violations of the federal securities laws.
On December 10, 2024, Dave & Buster's reported that "Chris Morris, the Company's Chief Executive Officer ("CEO"), has tendered his resignation as CEO and Director to pursue other interests. The Board has been working with Heidrick & Struggles, a global executive search firm, for the last few months to assist in identifying the Company's next permanent CEO and has already started meeting potential candidates." Following this news, Dave & Buster's stock fell over 14% intraday on December 11, 2024.
If you suffered a loss on your Dave & Buster's Entertainment, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DMC Global Inc. (NASDAQ: BOOM) securities.
If you suffered a loss on your DMC Global Inc. investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: May 03 2024 - Nov 04 2024
CASE DETAILS: The filed complaint alleges that DMC Global Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the goodwill associated with Acadia products was overstated due to the adverse events and circumstances affecting that reporting segment; (ii) DMC Global’s materially inadequate internal systems and processes were adversely affecting its operations; (iii) the Company’s inadequate systems and processes prevented it from ensuring reasonably accurate guidance and that its public disclosures were timely, accurate, and complete; (iv) as a result, defendants misrepresented DMC Global’s operations and financial results; and/or (v) as a result, the Company’s public statements were materially false, misleading, or lacked a reasonable basis when made.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Winnebago Industries, Inc. (NYSE: WGO) concerning potential violations of the federal securities laws.
On September 23, 2024, Hunterbrook Media published an article called "'Grand Deception'- Winnebago Muzzles Outcry Over Major Problem That Owners Say Makes RVs Dangerous, Untowable, Worthless." In this article, Hunterbrook said Winnebago's "best-selling Grand Design RVs" appear to be "experiencing frame failure, potentially affecting thousands of units sold for more than a billion dollars. This defect has led to costly damage and potential safety hazards, and rendered some RVs unroadworthy." Further, the article stated "Winnebago has used NDAs, buybacks, and online censorship to silence complaints about frame failure[.]" Following this news, Winnebago's stock fell over 2% on the same day.
If you suffered a loss on your Winnebago Industries, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Airship AI Holdings, Inc. (NASDAQ: AISP) concerning potential violations of the federal securities laws.
Airship AI issued a press release on November 14, 2024, reporting its financial and operational results for the third quarter of 2024. Among other items, Airship AI reported revenue of $2.9 million, missing consensus estimates by $1.9 million. In the press release, President Paul Allen stated that the Company "saw several large opportunities pushed out to FY 2025 or drastically cut due to budget challenges across several federal agencies" and that "the completion of the capital raise late in the quarter caused delays in bringing in several opportunities as the funds were needed to cover the cost of goods sold for those opportunities." Following this news, Airship AI's stock price fell over 22% on November 15, 2024.
If you suffered a loss on your Airship AI Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Cato Corporation (NYSE: CATO) concerning potential violations of the federal securities laws.
Cato issued a press release on November 22, 2024, stating that "[i]n light of the current economic conditions and current sales trends the Board of Directors of [Cato] suspended the regular quarterly dividend." Following this news, Cato's stock price fell sharply during intraday trading.
If you suffered a loss on your The Cato Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Macy's, Inc. (NYSE: M) concerning potential violations of the federal securities laws.
Macy's issued a press release on November 25, 2024, announcing its preliminary third-quarter 2024 results. Therein, Macy's disclosed that "during the preparation of its unaudited condensed consolidated financial statements for the fiscal quarter ended November 2, 2024, it identified an issue related to delivery expenses in one of its accrual accounts" and "consequently initiated an independent investigation." Macy's reported that "[a]s a result of the independent investigation and forensic analysis, the company identified that a single employee with responsibility for small package delivery expense accounting intentionally made erroneous accounting accrual entries to hide approximately $132 to $154 million of cumulative delivery expenses from the fourth quarter of 2021 through fiscal quarter ended November 2, 2024." Macy's further advised that "[t]he individual who engaged in this conduct is no longer employed by the company." Following this news, Macy's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Macy's, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Oklo Inc. (NYSE: OKLO) concerning potential violations of the federal securities laws.
Kerrisdale Capital published a short report on Oklo on November 20, 2024, which it described as "a $3B nuclear energy company that went public via SPAC six months ago - with no regulator-approved design, no revenue for years, and no proven commercial viability for its planned 15-50 MWe microreactors." The Kerrisdale report asserted that Oklo faces massive technical and financial challenges" in its quest to become the owner-operator of hundreds of nuclear "powerhouses" and that "[i]n classic SPAC fashion, Oklo has sold the market on inflated unit economics while grossly underestimating the time and capital it will take to commercialize its product. . . . Virtually every aspect of Oklo's investment case warrants skepticism." Following this news, Oklo's stock price fell over 3% on the same day.
If you suffered a loss on your Oklo Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Target Corporation (NYSE: TGT) concerning potential violations of the federal securities laws.
On November 20, 2024, Target reported earnings well below Wall Street's expectations, which the big retail chain blamed on slower-than-expected demand. Target executives cited continued weakness in discretionary sales, which include things like apparel and consumer electronics, as well as costs tied to the short-lived ports strike. Following this news, Target's shares dropped over 15% in premarket trading.
If you suffered a loss on your Target Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Arvinas, Inc. (NASDAQ: ARVN) concerning potential violations of the federal securities laws.
On May 1, 2025, Arvinas issued a press release announcing a re-prioritization of its vepdegestrant development plan and research portfolio. Management also announced it was initiating cost reductions, including cutting approximately one-third of its workforce. Following this news, ARVN’s stock price fell by $2.39 per share, or approximately 25% to close at $7.23 per share.
If you suffered a loss on your Arvinas securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Codere Online Luxembourg, S.A. (NASDAQ: CDRO) concerning potential violations of the federal securities laws.
Codere issued a press release on November 18, 2024, announcing receipt of "a staff determination letter . . . , from the Listing Qualifications Department of The Nasdaq Stock Market LLC (‘Nasdaq'), notifying the Company of the determination from the Nasdaq Staff (the ‘Staff') to delist the Company's securities from The Nasdaq Stock Market, given the Company had not filed its Form 20-F for the year ended December 31, 2023 . . . in accordance with continued Listing Rule 5250(c)(1)[.]" Following this news, Codere's stock price declined sharply during intraday trading on November 19, 2024.
If you suffered a loss on your Codere Online Luxembourg, S.A. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Incyte Corporation (NASAQ: INCY) concerning potential violations of the federal securities laws.
On November 18, 2024, INCY announced it will pause enrollment in the Phase 2 study of its drug INCB000262 in chronic spontaneous urticaria (CSU) due to “the observation of certain in vivo preclinical toxicology findings.” The Company also announced the discontinuation of the development of its drug INCB000547 for patients with cholestatic pruritus (CP). Both of these drugs stem from Incyte’s $750 million acquisition of Escient Pharmaceuticals earlier this year. Following this news, Incyte’s stock price fell by $9.05 per share, or approximately 12% to close at $67.92 per share.
If you suffered a loss on your Incyte Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Quanterix Corporation (NASDAQ: QTRX) concerning potential violations of the federal securities laws.
After the market closed, on November 12, 2024, Quanterix announced that it had “identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021,” which had affected the valuation of its inventory. As a result, the company stated that the financial statements reflecting these errors should no longer be relied upon. Following this news, Quanterix’s stock price fell over 18% on November 13, 2024.
If you suffered a loss on your Quanterix Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Neurogene Inc. (NASDAQ: NGNE) concerning potential violations of the federal securities laws.
Neurogene issued a press release on November 11, 2024, reporting "interim clinical data in the first four participants in the low-dose cohort of its ongoing Phase 1/2 open-label trial designed to evaluate NGN-401 gene therapy for the treatment of female pediatric patients with Rett syndrome." Although Neurogene characterized the data as "positive", one of two patients given a high dose reported an emerging treatment-related serious adverse event that the Company described as "consistent with known risks of [adeno-associated virus] gene therapy[.]" Following this news, Neurogene's stock price fell over 44% on November 12, 2024.
If you suffered a loss on your Neurogene Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Clear Secure, Inc. (NYSE: YOU) concerning potential violations of the federal securities laws.
On November 7, 2024, Clear published its third quarter results, reporting a slowdown in new users of its annual membership service. Active Clear Plus members grew only 0.8% in the quarter, the smallest gain in over two years. This slowdown comes on the back of price increases that have seen family prices increase 70% year over year from $70 to $119. Following this news, Clear’s stock price fell by $9.92 per share to close at $28.53 per share.
If you suffered a loss on your Clear Secure, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Universal Display Corporation (NASDAQ: OLED) concerning potential violations of the federal securities laws.
On October 30, 2024, Universal announced 3Q 2024 revenue results that fell short of consensus and lowered its CY2024 revenue guidance. Analysts questioned the continued delay and lack of an “explicit timeline” in the commercial availability of its phosphorescent blue emissive system. Following this news, OLED’s stock price fell by $22.84 per share, or approximately 12% to close at $180.32 per share.
If you suffered a loss on your Universal Display Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Proficient Auto Logistics, Inc. (NASDAQ: PAL) concerning potential violations of the federal securities laws.
On October 16, 2024, Proficient Auto Logistics issued a report pertaining to anticipated operating and financial metrics for the third quarter of fiscal year 2024. The Company stated that they estimated revenue for the third quarter to be in the range of $90 to $92 million, reflecting a decrease of 14 to 16% relative to the combined revenue of the third quarter of 2023. Following this news, the Company's stock dropped over 28% in the subsequent trading session.
If you suffered a loss on your Proficient Auto Logistics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Coursera, Inc. (NYSE: COUR) concerning potential violations of the federal securities laws.
On April 29, 2024, Coursera reported 1Q 2024 financial results that missed revenue estimates and then lowered its full-year guidance. Management attributed this decrease to “demand softening” in North America and “delays in a new content launch.” Analysts commenting on the issue mention the failure of Coursera’s artificial intelligence (AI) products to drive stronger financial results. Following this news, COUR’s stock price fell by $1.67 per share, or approximately 14% to close at $10.22 per share.
If you suffered a loss on your Coursera, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Celanese Corporation (NYSE: CE) concerning potential violations of the federal securities laws.
On November 4, 2024, Celanese issued a press release reporting its financial results for the third quarter of 2024. Celanese's reported earnings adjusted for one-time items in the third quarter were $2.44 per share, compared with a consensus estimate of $2.84 per share. Celanese also reported revenue of $2.65 billion, representing a 2.6% year-over-year decline and falling short of consensus estimates of $2.69 billion. In the press release, Celanese's Chief Executive Officer stated that "[i]n the third quarter, we faced a severely constrained demand environment that, in some cases like auto, degraded swiftly" and cautioned investors that "[w]e expect demand conditions to worsen in the fourth quarter, as automotive and industrial segments react to recent dynamics by seasonally destocking at heavier than normal levels." Following this news, Celanese's stock price fell over 26% on November 5, 2024.
If you suffered a loss on your Celanese Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into First Northwest Bancorp (NASDAQ: FNWB) concerning potential violations of the federal securities laws.
On October 25, 2024, FNWB announced that its previously reported financial results for the second quarter of 2024 could no longer be relied upon due to an additional $6.6 million in charge-offs and a higher provision for consumer loans. As a result, the company restated its total provision for credit losses on loans to $8.7 million. FNWB also revealed that a material weakness existed in its internal controls over financial reporting as of June 30, 2024. Following this news, FNWB’s stock price dropped over 2% on October 28, 2024.
If you suffered a loss on your First Northwest Bancorp securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Viking Therapeutics, Inc. (NASDAQ: VKTX) concerning potential violations of the federal securities laws.
On November 3, 2024, Viking released positive trial data for VK2735, the Company's anti-obesity drug, as part of a presentation at the Obesity Week medical meeting, causing Viking's stock price to climb 9% during intraday trading on November 4, 2024. However, analysts were quick to note that Viking may face production problems for VK2735, especially for 100mg or higher doses. Analysts at Deutsche Bank stated in a note that scaling up production for the drug "will be costly with capital requirements and expertise beyond what [Eli] Lilly (LLY) and Novo [Nordisk] (NVO) currently have[.]" Following this news, Viking's stock price fell over 13% on November 4, 2024.
If you suffered a loss on your Viking Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Este Lauder Companies Inc. (NYSE: EL) concerning potential violations of the federal securities laws.
On October 31, 2024, Estée Lauder issued a press release announcing its fiscal 2025 first quarter results. Among other items, Estée Lauder reported revenue of $3.36 billion, missing consensus estimates and representing a decline of 4.5% from the same period in the prior year. Estée Lauder attributed the results to "worsened consumer sentiment in China" and "lower replenishment orders in Asia travel retail," among other factors. The Company declared a quarterly dividend of $0.35 per share, a reduction of its previous quarterly dividend of $0.66 per share. Following this news, Estée Lauder's stock price fell over 20% on the same day.
If you suffered a loss on your The Este Lauder Companies Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Bancorp, Inc. (NASDAQ: TBBK) concerning potential violations of the federal securities laws.
On October 24, 2024, Bancorp issued a press release announcing its financial results for the third quarter of 2024. Among other items, Bancorp reported GAAP earnings per share of $1.04, missing consensus estimates by $0.08. The Company attributed the disappointing results to the addition of "a new a new CECL factor . . . which increased the provision for credit losses and resulted in an after-tax reduction in net income of $1.5 million"; "[p]rior period interest income reversals on real estate bridge loans transferred to nonaccrual or modified, [which] resulted in an after-tax reduction in net income of $1.2 million"; and "[a] loss resulting from a transaction processing delay [which] increased non-interest expense and resulted in an after-tax reduction in net income of approximately $900,000." Following this news, Bancorp's stock price fell over 14% on October 25, 2024.
If you suffered a loss on your The Bancorp, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Enphase Energy, Inc. (NASDAQ: ENPH) concerning potential violations of the federal securities laws.
On October 22, 2024, Enphase issued a press release announcing its financial results for the third quarter of 2024. Among other items, Enphase reported weaker than expected earnings and revenue, and forecast fourth quarter revenues that fell short of analyst expectations. Guggenheim downgraded Enphase to Sell from Neutral, noting that the Company "is losing share to Chinese competitors who are willing to sell at less than half Enphase's level." Following this news, Enphase's stock price fell over 14% on October 23, 2024.
If you suffered a loss on your Enphase Energy, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into CECO Environmental Corp. (NASDAQ: CECO) concerning potential violations of the federal securities laws.
On October 29, 2024, CECO issued a press release announcing its financial results for the third quarter of 2024. Among other items, CECO reported non-GAAPP earnings per share of $0.14, missing consensus estimates by $0.06, and revenue of $135.51 million, representing a 9.3% decline year-over-year and missing consensus estimates by $20.43 million. In the press release, CECO's Chief Executive Officer stated that "[w]e were disappointed that we fell short of the anticipated quarterly revenue and income outlook as a handful of customer-driven delays in larger projects could not be overcome by continued progress with margin expansion and other actions." Following this news, CECO's stock price fell over 14% on the same day.
If you suffered a loss on your CECO Environmental Corp. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Huntington Ingalls Industries, Inc. (NYSE: HII) concerning potential violations of the federal securities laws.
On October 31, 2024, Huntington Ingalls reported Q3 earnings that fell considerably short of analyst estimates, including a 34.2% miss on EPS. The Company's gross and operating margins both also fell from the same quarter in the previous year. Following this news, Huntington Ingalls stock fell over 26% on that same day.
If you suffered a loss on your Huntington Ingalls Industries, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Myriad Genetics, Inc. (NASDAQ: MYGN) concerning potential violations of the federal securities laws.
On October 31, 2024, it was revealed that UnitedHealth Group ("UnitedHealth") would no longer cover GeneSight, Myriad's genetic test to help determine which mental health medications are likely to work with an individual patient, beginning January 1, 2025. Specifically, market analysts reported that a document from UnitedHealth stated that the coverage is ending as tests for behavioral health, which includes GeneSight, are "unproven" and "not medically necessary." Following this news, Myriad's stock price fell over 18% on November 1, 2024.
If you suffered a loss on your Myriad Genetics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Janus International Group, Inc. (NYSE: JBI) concerning potential violations of the federal securities laws.
Janus issued a press release on October 29, 2024 announcing its financial results for its fiscal third quarter. The release disclosed, in part, revenue of $230.1 million, representing a year-over-year decline of 17.9%, and missing consensus estimates by $18.11 million. Further, Janus updated its full-year revenue guidance to a range of $910 million to $925 million, compared to consensus estimates of $1 billion, citing headwinds from macroeconomic factors, interest rate uncertainty, and persistent project delays. On this news, Janus's stock price fell almost 30% to close at $7.24 per share on October 29, 2024.
If you suffered a loss on your Janus securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Applied Materials, Inc. (NASDAQ: AMAT) concerning potential violations of the federal securities laws.
On October 15, 2024, the investment research firm Hedgeye added Applied Materials as a new short idea, claiming to have "tested [management's] conclusions" with respect to the Company's growth "and found it may not look as good as it seems," and asserting that "[f]rom a financial comparison, [Applied Materials] actually look[s] the worst among its peers in several categories[.]" Following this news, Applied Materials' stock price fell over 10% on the same day .
If you suffered a loss on your Applied Materials, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Byrna Technologies Inc. (NASDAQ: BYRN) concerning potential violations of the federal securities laws.
On October 29, 2024, Bonitas Research issued a report questioning Byrna’s primary sales channels, sales growth, and profitability. The report states that “Byrna’s earnings call highlighted the specific importance of its ‘Premier Dealer’ network and disclosed Byrna had twenty (20) ‘Premier Dealers’ as of April 5, 2024. We found some Byrna ‘Premier Dealers’ were secondary businesses using ad-hoc shooting ranges in garages and back alleys with little to no retail presence.” Bonitas Research also contacted 20% of Byrna’s Authorized Dealers, revealing multiple ‘Authorized Dealers’ with no online presence nor independent retail storefronts, including a car wash, a tea shop, a uniform embroidery shop, and a barbershop. We found that Byrna’s “Authorized Dealer” list included storefronts that did not carry launchers in stock and had not placed a restocking order in the last 90 days.”
If you suffered a loss on your Byrna Technologies Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) concerning potential violations of the federal securities laws.
On October 28, 2024, TransMedics reported disappointing financial results for the third quarter of 2024, missing analyst expectations on both the top and bottom lines. Specifically, the Company reported earnings per share (“EPS”) of $0.12, missing EPS expectations of $0.29 by nearly 60%. TransMedics also reported revenue of $108.8 million, falling short of analysts’ $115 million estimate. Following this news, TransMedics stock dropped over 24% in after-hours trading.
If you suffered a loss on your TransMedics Group, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into DZS Inc. (OTC: DZSI) concerning potential violations of the federal securities laws.
The investigation concerns whether DZS and certain of its directors and/or officers failed to disclose to shareholders that: (i) certain of the Company's financial statements contained errors that would require DZS to restate its previously filed financial statements; and (ii) DZS had ongoing undisclosed issues with its internal controls over financial reporting.
If you suffered a loss on your DZS Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into DoubleVerify Holdings, Inc. (NYSE: DV) concerning potential violations of the federal securities laws.
DoubleVerify reported its quarterly financial results on May 7, 2024, including a reduction in its full-year revenue guidance. Following this news, shares of DoubleVerify fell over 38% on the next day. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
If you suffered a loss on your DoubleVerify Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into eXp World Holdings, Inc. (NASDAQ: EXPI) concerning potential violations of the federal securities laws.
The investigation concerns whether eXp and certain of its directors and/or officers failed to disclose to shareholders that: (i) the Company's top agents, also known as "Influencers," and executives were accused of sexually assaulting eXp's real estate agents at Company events; (ii) the Company lacked a process and system to detect and report sexual misconduct to the Company's Board of Directors (the "Board"); and (iii) the Board failed to effectively respond to reports it received of sexual misconduct.
If you suffered a loss on your eXp World Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Unisys Corporation (NYSE: UIS) concerning potential violations of the federal securities laws.
The Securities and Exchange Commission ("SEC") announced on October 22, 2024, that it had charged four companies, including Unisys, with "making materially misleading disclosures regarding cybersecurity risks and intrusions." Further, the SEC also charged Unisys with disclosure controls and procedures violations. Following this news, Unisys' stock fell over 8% on the same day.
If you suffered a loss on your Unisys Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Treace Medical Concepts, Inc. (NASDAQ: TMCI) concerning potential violations of the federal securities laws.
On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on “competitive pressure in its business.” Following this news, Treace’s stock price fell by $6.95 per share, or approximately 62% on the same day.
If you suffered a loss on your Treace Medical Concepts, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Mercer International Inc. (NASDAQ: MERC) concerning potential violations of the federal securities laws.
On October 16, 2024, Mercer issued a press release announcing its preliminary financial results for the third quarter of 2024. In the press release, Mercer stated that "our operating results for the quarter were constrained due to the occurrence of several unrelated events that impacted pulp production, including the previously announced unscheduled downtime of 23 days (approximately 35,500 ADMTs [air-dried metric tons]) at our Mercer Peace River mill, a slower than normal maintenance start-up and other production upsets at our Stendal Mill (approximately 26,500 ADMTs) and isolated mechanical incidents at our Celgar mill (approximately 9,200 ADMTs)." Following this news, Mercer's stock price fell over 3% on October 17, 2024.
If you suffered a loss on your Mercer International Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into CSX Corporation (NASDAQ: CSX) concerning potential violations of the federal securities laws.
CSX is the subject of a Bloomberg article published on October 17, 2024, which states that the Company "received a subpoena from the US Securities and Exchange Commission focused on previously disclosed accounting errors and certain non-financial performance metrics." According to the article, "The subpoena asked the railroad company to produce documents about accounting mistakes CSX disclosed in its previous quarterly report, according to a regulatory filing on Thursday. The company received the subpoena this month and is cooperating with the probe, CSX said in the filing." The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
If you suffered a loss on your CSX Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Stride, Inc. (NYSE: LRN) concerning potential violations of the federal securities laws.
On October 16, 2024, after a report from Fuzzy Panda Research alleged that Stride has been inflating its earnings by misleading investors about the impact of federal COVID-19 relief funds. The report claims that more than 25% of Stride’s EBITDA came from Elementary and Secondary School Emergency Relief (ESSER) funds, which expired in September 2024. The report also accuses Stride of hiding “ghost students” and failing to disclose schools leaving the company, alongside allegations of overbilling and fraudulent reimbursement claims. Following this news, shares of Stride fell 5% the same day.
If you suffered a loss on your Stride, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Service Properties Trust (NASDAQ: SVC) concerning potential violations of the federal securities laws.
On October 16, 2024, SVC announced a quarterly dividend of $0.01 per share, representing a 95% decrease from its prior dividend of $0.20 per share. SVC also announced plans to sell roughly half of its hotel properties in order to boost its liquidity and pay down debt. Following this news, SVC's stock price fell over 16% the same day.
If you suffered a loss on your Service Properties Trust securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Shoals Technologies Group, Inc. (NASDAQ: SHLS) concerning potential violations of the federal securities laws.
The investigation concerns whether Shoals and certain of its directors and/or officers failed to disclose to shareholders that: (i) certain of the Company's products used for solar power generation were not of the highest levels of quality and reliability as Shoals claimed; (ii) the Company received numerous reports of defects in wire harnesses it had installed in a number of solar fields; and (iii) it would cost Shoals millions of dollars to remediate the defects with its products.
If you suffered a loss on your Shoals Technologies Group, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) concerning potential violations of the federal securities laws.
On October 4, 2024, Biodexa reported updated data on progression-free and overall survival from a Phase 1 study of its drug MX110 in the treatment of recurrent glioblastoma. Biodexa disclosed that of the four patients who were enrolled in Cohort A of the study, two are now deceased, with one achieving an overall survival of 12 months and the other 13 months since the start of treatment. Follow this news, Biodexa's stock price fell over 7% on the same day.
If you suffered a loss on your Biodexa Pharmaceuticals Plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Rayonier Advanced Materials Inc. (NYSE: RYAM) concerning potential violations of the federal securities laws.
On October 14, 2024, Rayonier issued a press release "report[ing] that an isolated fire occurred at its Jesup, Georgia facility on October 11 at approximately 6 p.m. during planned maintenance activity[,]" advising that "[w]hile the plant's C line operations have resumed, the A and B lines will remain offline for repairs with a target start date the week of October 28. Rayonier stated that "[w]hile the Company continues to assess the financial cost of the incident, the EBITDA impact is currently expected to be in the range of $15 to $20 million, subject to any potential insurance recovery." Following this news, Rayonier's stock price fell over 9% on the same day.
If you suffered a loss on your Rayonier Advanced Materials Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Novavax, Inc. (NASDAQ: NVAX) concerning potential violations of the federal securities laws.
On October 16, 2024, NVAX announced the Food and Drug Administration placed a clinical hold on the development of the company’s combination influenza and Covid-19 (CIC) shot and its stand-alone influenza vaccine. The hold was placed following a “serious adverse event of motor neuropathy” that occurred in a CIC Phase 2 trial participant outside the U.S., who received the vaccine in January of 2023. Following this news, NVAX’s stock price fell by $2.18 per share, or approximately 17% in premarket trading.
If you suffered a loss on your Novavax, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Tesla, Inc. (NASDAQ: TSLA) concerning potential violations of the federal securities laws.
On October 10, 2024, Tesla unveiled the Company's Cybercab self-driving concept car at the Company's "We, Robot" event and announced plans to create a fleet of autonomous vehicles and robots, with the goal of starting production before 2027. Analysts and investors did not react positively to Tesla's announcements. An analyst at Jefferies published a note entitled "We, Underwhelmed", analysts at Barclays said that the revelations failed to highlight any near-term opportunities for Tesla, and Piper Sandler analysts opined that "most trading-oriented firms will be underwhelmed by the robo-taxi unveiling." Following this news, the Company's stock price fell over 8% on October 11, 2024.
If you suffered a loss on your Tesla, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Shattuck Labs, Inc. (NASDAQ: STTK) concerning potential violations of the federal securities laws.
On October 1, 2024, Shattuck issued a press release announcing the discontinuation of its lead experimental therapy SL-172154 following disappointing early-stage data. Specifically, Shattuck's decision came after an interim Phase 1 readout indicated that SL-172154, compared to azacitidine monotherapy, failed to improve median overall survival in certain patients with myeloid leukemia and myelodysplastic syndromes in combination with azacitidine. Following this news, Shattuck's stock price fell over 44% on the same day.
If you suffered a loss on your Shattuck Labs, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Xometry, Inc. (NASDAQ: XMTR) concerning potential violations of the federal securities laws.
On March 1, 2023, Xometry announced an adjusted EBITDA loss of $14.2 million for the fourth quarter of 2022 due to a “revenue shortfall” and “lower gross margins quarter-over-quarter.” The Company blamed “macroeconomic factors” including inflation that “changed” supplier behavior and “slowing demand.” Further, the Company announced that it would be implementing a “5-point strategic plan” that included “aggressively” reducing operating expenses. Xometry also announced its full year financial guidance for fiscal year 2023 which was significantly worse than analysts had been expecting, including an adjusted EBITDA loss of between $20 million and $22 million instead of the $7.3 million loss projected by analysts. Following this news, Xometry’s stock price fell by $12.01 per share, or approximately 40%, to close at $18.40 per share.
If you suffered a loss on your Xometry, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into First Solar, Inc. (NASDAQ: FSLR) concerning potential violations of the federal securities laws.
On October 10, 2024, Jefferies analysts pared their expectations for FirstSolar's upcoming third-quarter results, stating that "[g]oing into 3Q, we expect a slight miss with lower volume versus consensus" and that "[w]e also lower volume estimates for 2025/2026, which are 8%/4% below consensus and are below 2024 guidance." Jefferies said that it expected First Solar's focus this earnings season to be on potential delays, impact on module pricing from Antidumping and Countervailing Duties determinations, and thoughts on selling excess Indian capacity into the U.S. Following this news, First Solar's stock price fell over 9% on October 10, 2024.
If you suffered a loss on your First Solar, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) concerning potential violations of the federal securities laws.
On October 9, 2024, ADMA Biologics disclosed the surprise resignation of its independent outside auditor CohnReznick LLP. The news caused a precipitous decline in the price of ADMA Biologics stock. ADMA Biologics stock price fell over 20% on October 10, 2024.
If you suffered a loss on your ADMA Biologics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into CAE Inc. (NYSE: CAE) concerning potential violations of the federal securities laws.
Investors who purchased CAE on the New York Stock Exchange (“NYSE”) may have been affected by violations of federal securities laws. Specifically, CAE executives allegedly made false statements and/or concealed that: (i) several of CAE’s pre-COVID fixed-price defense contracts had incurred severe cost overruns due to supply chain and labor issues – as the segment was significantly impacted by the pandemic – which dented the segment’s profit and operating margin; and (ii) CAE failed to successfully reduce hard costs and achieve a sufficient level of operational efficiency, particularly with respect to such contracts, necessitating a re-baselining of the defense business and significant associated charges.
If you suffered a loss on your CAE Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Torrid Holdings Inc. (NYSE: CURV) concerning potential violations of the federal securities laws.
On October 7, 2024, Torrid announced the termination of "Ms. Elizabeth Muñoz-Guzman, the [Company's] Executive Vice President and Chief Creative Officer . . . effective as of October 4, 2024[.]" Following this news, Torrid's stock price fell over 10% the same day.
If you suffered a loss on your Torrid Holdings Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Beyond, Inc. (NYSE: BYON) concerning potential violations of the federal securities laws.
After the market closed on May 6, 2024, Beyond announced the company's first quarter 2024 financial results and revealed first quarter total net revenue of $382 million, an increase of only 0.3% year-over-year, and a first quarter net loss of $74 million. Additionally, Beyond declined to reiterate its previously-issued goal to achieve $2 billion of revenue in 2024 and a $3 billion revenue run rate by the end of 2025. Following this news, Beyond's share price fell over 24% on May 7, 2024.
If you suffered a loss on your Beyond, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Franklin Resources, Inc. (NYSE: BEN) concerning potential violations of the federal securities laws.
Franklin subsidiary Western Asset Management Company issued a press release on August 21, 2024, announcing that co-Chief Investment Officer Ken Leech “is on a leave of absence, effective immediately” after “receiv[ing] a Wells Notice from the Staff of the U.S. Securities and Exchange Commission”. That same day, Bloomberg reported that “[f]ederal prosecutors in New York are investigating whether a Western Asset Management executive allocated winning trades to favored accounts, as part of a criminal probe into a practice known as ‘cherry-picking.’” Following this news, Franklin’s stock price fell over 12% on August 21, 2024.
If you suffered a loss on your Franklin Resources, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Nomura Holdings, Inc. (NYSE: NMR) concerning potential violations of the federal securities laws.
Media outlets reported on September 30, 2024, that Nomura was excluded as lead manager for several yen bond deals after an investigation by Japan's securities watchdog into suspected market manipulation in government bond futures found rule violations by Nomura. Following this news, Nomura's American depositary receipt ("ADR") price fell over 4% on September 30, 2024.
If you suffered a loss on your Nomura Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. (NASDAQ: MEDP) concerning potential violations of the federal securities laws.
Jefferies downgraded Medpace, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding. Following this news, Medpace's stock price fell over 9% on September 25, 2024.
If you suffered a loss on your Medpace Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Humana Inc. (NYSE: HUM) concerning potential violations of the federal securities laws.
On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana. The complaint alleged "that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers' Medicare Advantage plans." On this news, Humana's stock price fell $6.20 per share, or 2.36%.
If you suffered a loss on your Humana Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Travere Therapeutics, Inc. (NASDAQ: TVTX) concerning potential violations of the federal securities laws.
Travere issued a press release on September 26, 2024, "announc[ing] a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU)." Travere stated that "[t]he voluntary enrollment pause enables the Company to work to address necessary process improvements in manufacturing scale-up to support commercial scale manufacturing as well as full enrollment in the HARMONY Study" and that "[t]he voluntary enrollment pause was enacted following the Company's determination that the desired drug substance profile was not achieved in the recent scale-up process." Following this news, Travere's stock price fell over 6% on September 27, 2024.
If you suffered a loss on your Travere Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Dollar General Corporation (NYSE: DG) concerning potential violations of the federal securities laws.
Dollar General lowered its outlook for same-store sales and earnings per share on August 29, 2024. According to CNBC, CEO Todd Vasos said, ""While we believe the softer sales trends are partially attributable to a core customer who feels financially constrained, we know the importance of controlling what we can control." Following this news, shares of Dollar General dropped 32% on the same day. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
If you suffered a loss on your Dollar General Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Laser Photonics Corporation (NASDAQ: LASE) concerning potential violations of the federal securities laws.
Laser Photonics disclosed in a filing with the U.S. Securities and Exchange Commission on May 29, 2025, that it had “received a notice from Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC (‘Nasdaq’) stating that since it had not received the Company’s Form 10-Q for the period ended March 31, 2025, and because the Company remains delinquent in filing its Form 10-K for the period ended December 31, 2024 (the ‘Initial Delinquent Filing’), the Company does not comply with Nasdaq’s Listing Rules for continued listing.” Laser Photonics said that “the Company has until June 16, 2025, to submit a plan to regain compliance with respect to these delinquent reports.” Laser Photonics specified that the delay was “primarily due to [Laser Photonics’] acquisition of certain assets of CMS in November 2024 . . . , approximately six weeks before the end of [Laser Photonics’] fiscal year, for approximately $1 million out of the bankruptcy proceedings of CMS’s former parent company.” Following this news, Laser Photonics’ stock price fell over 6% on May 30, 2025.
If you suffered a loss on your Laser Photonics Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into SAP SE (NYSE: SAP) concerning potential violations of the federal securities laws.
On September 25, 2024, Bloomberg News reported that the U.S. Department of Justice was investigating SAP and other companies for potentially conspiring to overcharge U.S. government agencies over the course of a decade, by "fix[ing] prices on sales to the U.S. military and other parts of the government". Following this news, SAP's American depositary receipt ("ADR") price fell over 3% on September 25, 2024.
If you suffered a loss on your SAP SE securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into SIGA Technologies, Inc. (NASDAQ: SIGA) concerning potential violations of the federal securities laws.
On September 25, 2024, video was released of Dr. Varma detailing how he and SIGA were engaged in a media "spin" campaign to salvage TPOXX as a mpox treatment and preserve the Company's stock price despite disappointing top line results in the PALM 007 clinical trial. According to Dr. Varma, the media "spin" campaign was designed to convince investors "not to dump the stock, thinking that the Company was worthless" while conceding that pursuit of TPOXX as a treatment for mpox might not even be worth it because "there's only a few thousand cases in the United States." Following this news, the stock dropped over 15% on September 25, 2024.
If you suffered a loss on your SIGA Technologies, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





